Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR.

Author: GuoFengjing, GuoJiachao, HuangJunming, JingXingzhi, LiWeijin, LvZhengtao, RenRanyue, WuYingxing, XiangWei, XiaoJun, ZhangJiaming

Paper Details 
Original Abstract of the Article :
Pregnane X receptor (PXR) which belongs to the nuclear hormone receptor superfamily plays vital roles in several biological functions, especially in the inflammatory procedure. Besides that, PXR is revealed by recent studies to have essential effects on bone tissue. As an agonist of PXR, meclizine i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632684/

データ提供:米国国立医学図書館(NLM)

Meclizine: A Potential New Weapon Against Osteoporosis?

The world of bone health is vast and complex, with a multitude of factors impacting bone density and strength. This research dives into the fascinating world of osteoclasts, the bone-resorbing cells, and explores the potential of meclizine, a common medication for nausea and vomiting, to inhibit their activity. It's like discovering a hidden oasis in the desert, a place where we can find relief from the relentless erosion of bone tissue.

Meclizine's Impact on Osteoclast Activity

The study found that meclizine effectively inhibited osteoclast formation and bone resorption both in vitro and in vivo, suggesting a potential for treating osteoporosis. The researchers identified the pregnane X receptor (PXR) as a key player in this process, with meclizine acting as an agonist, essentially activating PXR. They observed that meclizine reduced the expression of several osteoclast-specific genes, indicating a direct impact on the cells' ability to break down bone. This is like finding a naturally occurring mineral that can solidify the sand dunes, preventing them from being blown away by the wind.

A New Avenue for Osteoporosis Treatment

The research suggests that meclizine could be a promising therapeutic candidate for osteoporosis, offering a novel approach to combatting bone loss. However, further research is needed to confirm its effectiveness and safety in human patients. As Dr. Camel, I'm always fascinated by the hidden potential of seemingly ordinary substances. It's like discovering a new desert flower, one that can not only survive in harsh conditions but also possess medicinal properties.

Dr.Camel's Conclusion

This study provides a fascinating insight into the potential of meclizine for treating osteoporosis. Its ability to inhibit osteoclast activity and regulate PXR signaling pathways opens up new avenues for bone health research. It's a reminder that even in the vast and seemingly barren landscape of bone disease, there are still hidden treasures to be discovered.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-10-01
Further Info :

Pubmed ID

29046637

DOI: Digital Object Identifier

PMC5632684

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.